MDxHealth SA
Related Filers (6)
- Bleichroeder LP (4)
- MVM Partners, LLC (3)
- MVM Partners LLP (2)
- Biovest NV (2)
- TopMDx Ltd. (2)
- Nasdaq Stock Market LLC (1)
- Show More ...
Other (66)
6-K
Friday, 2/16/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/19/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
8-A12B/A
Friday, 11/24/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
25-NSE
Friday, 11/24/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Wednesday, 11/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 4/25/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 4/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 12/30/2022
Notice of Effectiveness
CORRESP
Wednesday, 12/28/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 12/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Monday, 12/19/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 11/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/26/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Monday, 8/15/2022
Exempt (Private) Offering
6-K
Tuesday, 8/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Monday, 4/25/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/23/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/9/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SEC STAFF LETTER
Thursday, 11/4/2021
None
CERT
Wednesday, 11/3/2021
Certification by an exchange approving securities for listing
EFFECT
Wednesday, 11/3/2021
Notice of Effectiveness
CORRESP
Monday, 11/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 11/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 11/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Monday, 11/1/2021
Registration statement for securities of certain foreign private issuers
8-A12B
Monday, 11/1/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
F-1/A
Thursday, 10/28/2021
Registration statement for securities of certain foreign private issuers
CORRESP
Wednesday, 10/13/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Wednesday, 10/13/2021
Registration statement for securities of certain foreign private issuers
SEC STAFF LETTER
Friday, 9/10/2021
None
Ownership (13)
SC 13G/A
Wednesday, 2/14/2024
Bleichroeder LP: Major Shareholders
SC 13D/A
Friday, 4/14/2023
TopMDx Ltd.: Major Shareholders
SC 13G/A
Friday, 3/17/2023
Biovest NV: Major Shareholders
4
Tuesday, 2/28/2023
MVM Partners, LLC: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/28/2023
MVM Partners, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Bleichroeder LP: Major Shareholders
SC 13D/A
Wednesday, 11/23/2022
MVM Partners, LLC: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Bleichroeder LP: Major Shareholders
SC 13G
Monday, 2/14/2022
Biovest NV: Major Shareholders
SC 13D
Monday, 12/27/2021
MVM Partners LLP: Major Shareholders
SC 13D
Wednesday, 12/1/2021
TopMDx Ltd.: Major Shareholders
3
Tuesday, 11/30/2021
MVM Partners LLP: Initial statement of beneficial ownership of securities
SC 13G
Friday, 11/12/2021
Bleichroeder LP: Major Shareholders
Prospectus (6)
424B5
Monday, 2/6/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 2/1/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B4
Friday, 11/5/2021
Prospectus filed pursuant to Rule 424(b)(4)
DRS/A
Thursday, 9/23/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 9/22/2021
Correspondence Related to Draft Registration Statement
DRS
Monday, 8/9/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy